Login to Your Account


Friday, November 10, 2017

Apellis Pharmaceuticals Inc., of Crestwood, Ky., said it priced its IPO of 10.7 million shares of common stock at $14 per share for total gross proceeds of approximately $150 million. In addition, the company has granted the underwriters a 30-day option to purchase up to 1.6 million additional shares of common stock at the public offering price.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription